| A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19 A Idris, A Davis, A Supramaniam, D Acharya, G Kelly, Y Tayyar, N West, ... Molecular Therapy 29 (7), 2219-2226, 2021 | 153 | 2021 |
| Potency of progestogens used in hormonal therapy: toward understanding differential actions JP Hapgood, D Africander, R Louw, RM Ray, JM Rohwer The Journal of steroid biochemistry and molecular biology 142, 39-47, 2014 | 112 | 2014 |
| The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the … Y Govender, C Avenant, NJD Verhoog, RM Ray, NJ Grantham, ... PloS one 9 (5), e96497, 2014 | 86 | 2014 |
| Exosome-mediated stable epigenetic repression of HIV-1 S Shrivastava, RM Ray, L Holguin, L Echavarria, N Grepo, TA Scott, ... Nature Communications 12, 5541, 2021 | 63 | 2021 |
| The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the … M Tomasicchio, C Avenant, A Du Toit, RM Ray, JP Hapgood PloS one 8 (5), e62895, 2013 | 57 | 2013 |
| Differential Glucocorticoid Receptor‐Mediated Effects on Immunomodulatory Gene Expression by Progestin Contraceptives: Implications for HIV‐1 Pathogenesis JP Hapgood, RM Ray, Y Govender, C Avenant, M Tomasicchio American journal of reproductive immunology 71 (6), 505-512, 2014 | 51 | 2014 |
| Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving … MF Maritz, RM Ray, AJ Bick, M Tomasicchio, JG Woodland, Y Govender, ... PloS one 13 (4), e0196043, 2018 | 34 | 2018 |
| Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2 TA Scott, A Supramaniam, A Idris, AA Cardoso, S Shrivastava, G Kelly, ... Molecular Therapy-Methods & Clinical Development 24, 355-366, 2022 | 31 | 2022 |
| Long Non-coding RNAs Mechanisms of Action in HIV-1 Modulation and the Identification of Novel Therapeutic Targets RM Ray, KV Morris Non-Coding RNA 6 (12), 2020 | 25 | 2020 |
| The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant … RM Ray, MF Maritz, C Avenant, M Tomasicchio, S Dlamini, ... Scientific reports 9 (1), 4334, 2019 | 24 | 2019 |
| Enhanced target cell specificity and uptake of lipid nanoparticles using RNA aptamers and peptides RM Ray, AH Hansen, M Taskova, B Jandl, J Hansen, C Soemardy, ... Beilstein Journal of Organic Chemistry 17 (1), 891-907, 2021 | 20 | 2021 |
| Control of LDL uptake in human cells by targeting the LDLR regulatory long non-coding RNA BM450697 RM Ray, AH Hansen, S Slott, M Taskova, K Astakhova, KV Morris Molecular Therapy-Nucleic Acids 17, 264-276, 2019 | 19 | 2019 |
| “Clicking” gene therapeutics: A successful union of chemistry and biomedicine for new solutions K Astakhova, R Ray, M Taskova, J Uhd, A Carstens, K Morris Molecular pharmaceutics 15 (8), 2892-2899, 2018 | 19 | 2018 |
| Conditionally Replicating Vectors Mobilize Chimeric Antigen Receptors against HIV RZ Urak, C Soemardy, R Ray, S Li, G Shevchenko, T Scott, L Lim, X Wang, ... Molecular Therapy-Methods & Clinical Development 19, 285-294, 2020 | 6 | 2020 |
| Differential effects of progestogens on HIV-1 replication and host gene expression in primary PBMCs and cervical tissue explants RM Ray University of Cape Town, 2015 | 4 | 2015 |
| Prospects and challenges of tissue-derived extracellular vesicles (Ti-EVs) JC Lee, RM Ray, TA Scott Molecular Therapy, 2024 | 3 | 2024 |
| Therapeutic targeting non-coding RNAs RM Ray, AD Lazar, LR Balahura, AE Mocanu-Dobranici, M Costache, ... Navigating Non-Coding RNA, 349-417, 2023 | 3 | 2023 |
| Surface engineering of metal-organic framework nanoparticles-based miRNA carrier: Boosting RNA stability, intracellular delivery and synergistic therapy W Jin, X Li, SM Argandona, RM Ray, MKTH Lin, F Melle, G Clergeaud, ... Journal of Colloid and Interface Science, 2024 | 2 | 2024 |
| DNA-PK inhibition enhances gene editing efficiency in HSPCs for CRISPR-based treatment of X-linked hyper IgM syndrome CM Pugliano, M Berger, RM Ray, K Sapkos, B Wu, A Laird, Y Ye, ... Molecular Therapy Methods & Clinical Development, 2024 | 2 | 2024 |
| Targeted zinc-finger repressors to the oncogenic HBZ gene inhibit adult T-cell leukemia (ATL) proliferation TA Scott, C Soemardy, RM Ray, KV Morris NAR cancer 5 (1), zcac046, 2023 | 2 | 2023 |
